GO:1905669 TORC1 complex assembly: Nutrient-Sensing Complex Assembly, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905669 (TORC1 complex assembly) describes the aggregation, arrangement and bonding together of components to form the TORC1 (target of rapamycin complex 1) complex, a central nutrient-sensing kinase complex.
• TORC1 assembly is dynamically regulated by nutrients, energy status, and lysosomal signaling scaffolds such as KICSTOR-GATOR1-SAMTOR.
• The core TORC1 components include mTOR, Raptor, mLST8, and associated proteins; assembly is required for downstream phosphorylation of substrates like S6K1 and 4E-BP1.
• Dysregulated TORC1 assembly and signaling are implicated in cancer, metabolic disorders, and autophagy-related pathologies.
• Experimental approaches to study TORC1 assembly include knockout, point-mutation, knock-in, and overexpression models, combined with proteomics, imaging, and functional assays.
• CRISPR-based gene editing enables precise dissection of TORC1 assembly factors and their roles in disease, offering a powerful platform for target validation.
Description
TORC1 (target of rapamycin complex 1) is a conserved serine/threonine kinase complex that integrates nutrient, energy, and growth factor signals to control cell growth, proliferation, and autophagy. The assembly of this complex, formally annotated as GO:1905669 (TORC1 complex assembly), is a prerequisite for its catalytic activity and downstream signaling. Understanding how TORC1 components aggregate and bond together is essential for deciphering how cells sense nutrients and coordinate anabolic and catabolic processes. Recent structural and functional studies have revealed that TORC1 assembly is not a spontaneous event but is orchestrated by lysosomal scaffolds and nutrient-sensing supercomplexes, including KICSTOR-GATOR1-SAMTOR. Dysregulation of TORC1 assembly and activity has been linked to cancer, metabolic diseases, and autophagy-related disorders. This article provides a research-grade overview of GO:1905669, covering its definition, molecular mechanism, key genes, disease relevance, and experimental strategies for investigation.
TORC1 complex assembly At A Glance
| GO ID | GO:1905669 |
|---|---|
| GO term | TORC1 complex assembly |
| Ontology | biological_process |
| Synonym | mTORC1 assembly; TORC1 formation; rapamycin and nutrient-sensitive TOR complex assembly; dTORC1 assembly |
| Major function | Assembly of the TORC1 kinase complex, enabling nutrient-dependent signaling to downstream effectors |
| Related cellular component | TORC1 complex (lysosomal membrane-associated) |
| Related molecular function | Protein kinase activity (downstream of assembly) |
| Key regulators | Nutrients (amino acids, glucose), energy status, lysosomal scaffolds (KICSTOR-GATOR1-SAMTOR) |
What Is GO:1905669?
According to the Gene Ontology, GO:1905669 (TORC1 complex assembly) is defined as the aggregation, arrangement and bonding together of a set of components to form a TORC1 complex. In other words, it encompasses the biogenesis of the TORC1 holoenzyme from its individual subunits and associated factors, a process that is spatially and temporally regulated in response to cellular cues such as nutrient availability.
Why Is TORC1 complex assembly Important in Cell Biology?
TORC1 complex assembly is a critical control point in cellular growth and metabolism because only the properly assembled complex can phosphorylate downstream substrates such as S6K1 and 4E-BP1, thereby promoting protein synthesis and inhibiting autophagy. Defects in assembly or its regulation contribute to a wide range of diseases, including cancer, where hyperactive mTORC1 signaling drives proliferation, and metabolic disorders where nutrient sensing is impaired. Therefore, understanding the molecular details of TORC1 assembly offers opportunities for therapeutic intervention and biomarker discovery.
• TORC1 assembly is required for nutrient-dependent activation of cell growth and proliferation.
• Dysregulated TORC1 assembly contributes to cancer pathogenesis, with MTOR mutations affecting complex activity and rapamycin sensitivity.
• TORC1 assembly is linked to autophagy regulation; energy metabolism and autophagy are interconnected through TORC1 signaling.
• Lysosomal nutrient-sensing supercomplexes (KICSTOR-GATOR1-SAMTOR) directly control TORC1 assembly and activity.
• TORC1 assembly influences lysosomal catabolic activity via V-ATPase regulation.
• Glycolysis-mediated activation of v-ATPase modulates TORC1 signaling in cardiomyopathy models.
• Distinct TORC1 signaling branches regulate proteasome assembly chaperone expression, linking assembly to proteostasis.
• TORC1 assembly is a potential target for rapamycin and rapamycin analogs in cancer and metabolic diseases.
• Network-based reconstruction of mTORC1 signaling highlights its broad impact on various diseases.
• Experimental models of TORC1 assembly (knockout, point mutation, knock-in) are essential for target validation.
What Happens During TORC1 complex assembly?
Initiation and scaffolding at the lysosome
In simple terms: The cell builds TORC1 on the surface of the lysosome, using a scaffold to bring the parts together.
TORC1 assembly begins at the lysosomal membrane, where nutrient-sensing supercomplexes such as KICSTOR-GATOR1-SAMTOR provide a platform for recruiting TORC1 components. This spatial organization ensures that assembly is coupled to nutrient availability and lysosomal signaling. The lysosomal scaffold proteins help to localize mTOR and its partners, facilitating the aggregation and bonding of the complex.
Recruitment of core subunits
In simple terms: The main protein parts, including mTOR and Raptor, are brought together.
The core TORC1 subunits include the kinase mTOR, the regulatory protein Raptor, and mLST8. Their assembly into a functional complex is a prerequisite for downstream phosphorylation events. The recruitment of these subunits is regulated by upstream signals, including amino acid availability and energy status, which converge on the lysosomal surface.
Conformational arrangement and activation
In simple terms: Once the parts are together, they rearrange to switch on the complex.
After recruitment, the TORC1 components undergo conformational changes that enable catalytic activity. This arrangement is influenced by associated proteins and post-translational modifications. Proper assembly leads to the activation of mTOR kinase activity, allowing it to phosphorylate substrates such as S6K1 and 4E-BP1. Disruption of this step impairs downstream signaling and affects processes like autophagy and protein synthesis.
Regulation by nutrient and energy status
In simple terms: The assembly process is turned on or off depending on what the cell eats and how much energy it has.
TORC1 assembly is dynamically regulated by nutrients (e.g., amino acids, glucose) and energy levels. The KICSTOR-GATOR1-SAMTOR supercomplex senses these cues and modulates the assembly process. Additionally, glycolysis-mediated activation of v-ATPase can influence TORC1 signaling, linking metabolic state to complex assembly. This regulation ensures that TORC1 is assembled only when conditions favor growth.
Assembly-linked quality control and disassembly
In simple terms: The cell also has ways to take the complex apart when it is no longer needed.
TORC1 assembly is reversible; under starvation or stress, the complex can disassemble to shut down growth signaling. This disassembly is important for switching to catabolic processes such as autophagy. The regulation of assembly and disassembly involves multiple factors, including the V-ATPase and lysosomal catabolic activity. Understanding these dynamics is key to targeting TORC1 in disease.
Key Genes Involved in GO:1905669 TORC1 complex assembly
The following genes and proteins are central to TORC1 complex assembly, based on published literature and pathway databases.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Core kinase subunit of TORC1; catalytic activity | Mutations affect rapamycin sensitivity and cancer progression |
| RPTOR | Regulatory-associated protein of mTOR; scaffold for assembly | Essential for TORC1 assembly and substrate recruitment |
| MLST8 | Stabilizes the TORC1 complex | Required for optimal kinase activity |
| AKT1S1 | PRAS40; inhibits TORC1 activity | Regulates assembly and downstream signaling |
| DEPTOR | Inhibitory subunit of TORC1 | Modulates complex stability and activity |
| TSC1 | Tuberous sclerosis complex 1; negative regulator of TORC1 | Mutations cause tuberous sclerosis and cancer |
| TSC2 | Tuberous sclerosis complex 2; GTPase-activating protein | Regulates TORC1 assembly via Rheb |
| RHEB | Activator of TORC1; promotes assembly | Oncogenic mutations drive TORC1 signaling |
| LAMTOR1 | Component of Ragulator; recruits TORC1 to lysosome | Required for amino acid-induced assembly |
| LAMTOR2 | Component of Ragulator | Facilitates TORC1 lysosomal localization |
| LAMTOR3 | Component of Ragulator | Part of the scaffold for assembly |
| LAMTOR4 | Component of Ragulator | Contributes to nutrient sensing |
| LAMTOR5 | Component of Ragulator | Essential for TORC1 activation |
| RRAGA | Rag GTPase; recruits TORC1 to lysosome | Mediates amino acid signaling |
| RRAGB | Rag GTPase | Facilitates TORC1 assembly |
| RRAGC | Rag GTPase | Required for nutrient-dependent assembly |
| RRAGD | Rag GTPase | Modulates TORC1 localization |
How Is TORC1 complex assembly Regulated?
TORC1 complex assembly is regulated by a complex network of nutrient-sensing pathways. The KICSTOR-GATOR1-SAMTOR supercomplex at the lysosome senses amino acid availability and controls the recruitment of TORC1 components. Energy status, mediated by AMPK and glycolysis, also influences assembly through v-ATPase and other mechanisms. Additionally, MTOR mutations can lead to hyperactive assembly and signaling, predicting rapamycin sensitivity. Distinct TORC1 signaling branches regulate specific downstream processes, such as proteasome assembly chaperone expression.
TORC1 complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Cancer, rapamycin sensitivity | Knock-in of hyperactivating mutations in cancer cell lines |
| TSC1/TSC2 | Tuberous sclerosis complex | Knockout in patient-derived cells |
| LAMTOR1-5 | Metabolic disorders, autophagy defects | Knockout in HEK293T or HeLa cells |
| RRAGs | Cancer, nutrient sensing | Point mutations to mimic GTP/GDP states |
| V-ATPase subunits | Cardiomyopathy, lysosomal dysfunction | Overexpression or knockout in cardiomyocytes |
TORC1 assembly in cancer
Dysregulated TORC1 assembly and signaling are hallmarks of many cancers. Cancer-associated MTOR mutations can be hyperactivating, leading to increased complex assembly and downstream growth signaling, and can predict sensitivity to rapamycin. Targeting TORC1 assembly factors may offer therapeutic strategies for cancers with aberrant mTORC1 activity.
TORC1 assembly and metabolic disorders
TORC1 assembly is tightly linked to energy metabolism and autophagy. Interplay between energy metabolism and autophagy is mediated by TORC1 signaling, and its dysregulation contributes to metabolic diseases such as diabetes and cardiomyopathy. Glycolysis-mediated activation of v-ATPase by nicotinamide mononucleotide ameliorates lipid-induced cardiomyopathy by repressing the CD36-TLR4 axis, highlighting the role of TORC1 assembly in metabolic regulation.
TORC1 assembly in autophagy and lysosomal function
TORC1 assembly controls lysosomal catabolic activity through regulation of V-ATPase assembly. When TORC1 is assembled and active, it inhibits autophagy; disassembly promotes autophagic flux. This connection is relevant to neurodegenerative diseases and lysosomal storage disorders where autophagy is impaired.
From TORC1 complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate TORC1 assembly? | Knockout cell lines (e.g., CRISPR-Cas9) |
| How do point mutations affect TORC1 assembly? | Point-mutation knock-in models |
| Does a specific isoform or tag affect assembly? | Tagged knock-in (e.g., GFP, HA) |
| What is the effect of gene overexpression on assembly? | Overexpression constructs in mammalian cells |
| Which genes are essential for TORC1 assembly? | CRISPR library screening |
| How does nutrient status affect assembly dynamics? | Live-cell imaging with fluorescent reporters |
How to Study the TORC1 complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| AP-MS | Protein-protein interactions, complex composition | Identifying TORC1 assembly factors |
| Live-cell imaging | Subcellular localization and dynamics | Visualizing assembly at lysosome |
| Phospho-Western blot | TORC1 kinase activity | Assessing assembly functionality |
| CRISPR knockout screens | Gene essentiality for assembly | Discovery of novel assembly regulators |
| Ribo-seq | Translation efficiency | Downstream effects of TORC1 assembly |
| Proximity ligation assay | In situ protein interactions | Detecting subunit assembly |
| Autophagy flux assay | Autophagic activity | Linking assembly to catabolism |
Proteomic analysis of TORC1 assembly
Affinity purification coupled with mass spectrometry (AP-MS) can identify TORC1 components and assembly intermediates. This approach has been used to characterize the KICSTOR-GATOR1-SAMTOR supercomplex. Quantitative proteomics can reveal changes in assembly stoichiometry under different conditions.
Imaging-based assays for assembly
Fluorescence microscopy and live-cell imaging of tagged TORC1 subunits (e.g., GFP-mTOR) allow visualization of assembly at the lysosome. Co-localization with lysosomal markers (LAMP1) confirms proper localization. FRET or proximity ligation assays can detect subunit interactions.
Functional assays for TORC1 activity
Phosphorylation of downstream substrates (S6K1, 4E-BP1) is a readout of TORC1 assembly and activity. Western blotting with phospho-specific antibodies is commonly used. Autophagy flux assays (LC3-II levels) reflect TORC1 inhibition.
Genetic screens and CRISPR libraries
Genome-wide CRISPR knockout screens can identify genes required for TORC1 assembly and signaling. Such screens have been applied to map the mTORC1 pathway. Bioinformatics analysis of screening data helps prioritize candidates for further study.
How CRISPR Can Be Used to Study GO:1905669 TORC1 complex assembly
Knockout
CRISPR-Cas9 knockout of TORC1 assembly genes (e.g., RPTOR, LAMTOR1) can abolish complex formation and downstream signaling. These models are used to study the requirement of specific factors for assembly and to validate drug targets.
Point Mutation
Point mutations in MTOR or other assembly genes can mimic disease-associated variants. For example, cancer-associated MTOR mutations that hyperactivate the complex can be introduced via CRISPR to study rapamycin sensitivity.
Knock-in
Knock-in of tagged versions of TORC1 subunits (e.g., GFP-mTOR) allows real-time visualization of assembly in live cells. This approach is valuable for studying dynamics and localization.
Overexpression
Overexpression of TORC1 components or assembly factors can drive complex formation and activate signaling. This is useful for gain-of-function studies and for producing large amounts of complex for biochemical analysis.
How EDITGENE Supports TORC1 complex assembly Research
Researchers studying TORC1 complex assembly-related genes often need to determine whether a candidate gene is causally involved in complex formation, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for TORC1 complex assembly research.
Frequently Asked Questions About TORC1 complex assembly
What is TORC1 complex assembly?
TORC1 complex assembly (GO:1905669) is the process by which the components of the TORC1 kinase complex aggregate and bond together to form a functional complex, enabling nutrient-dependent signaling.
What genes are involved in TORC1 complex assembly?
Key genes include MTOR, RPTOR, MLST8, and the Rag GTPases (RRAGA-D), as well as lysosomal scaffold proteins like LAMTOR1-5.
Where does TORC1 complex assembly occur?
Assembly primarily occurs at the lysosomal membrane, where nutrient-sensing supercomplexes recruit TORC1 components.
How is TORC1 complex assembly regulated?
It is regulated by nutrient availability, energy status, and lysosomal scaffolds such as KICSTOR-GATOR1-SAMTOR, as well as by MTOR mutations.
What diseases are associated with TORC1 complex assembly?
Dysregulation is linked to cancer, metabolic disorders, and autophagy-related diseases.
What methods are used to study TORC1 complex assembly?
Common methods include AP-MS, live-cell imaging, phospho-Western blot, and CRISPR screens.
Can CRISPR be used to study TORC1 complex assembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect assembly mechanisms.
What is the role of mTOR in TORC1 complex assembly?
mTOR is the catalytic subunit; its assembly with Raptor and mLST8 is essential for kinase activity.
How does nutrient signaling affect TORC1 assembly?
Amino acids and glucose promote assembly via Rag GTPases and lysosomal scaffolds, while starvation leads to disassembly.
What are the therapeutic implications of targeting TORC1 assembly?
Inhibiting assembly or activity with rapamycin analogs is a strategy for cancer and metabolic diseases.
Conclusion
TORC1 complex assembly (GO:1905669) is a fundamental biological process that integrates nutrient and energy signals to control cell growth and metabolism. Its dysregulation is implicated in cancer, metabolic disorders, and autophagy-related pathologies. Advances in CRISPR-based models and proteomic techniques continue to unravel the molecular details of assembly, offering new avenues for therapeutic intervention. EDITGENE provides essential tools to study this process and accelerate discovery.
References
- 1. Feng Y et al.. 2024. Interplay of energy metabolism and autophagy.. Autophagy 20(1):4-14 PMID: 37594406
- 2. Grabiner BC et al.. 2014. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.. Cancer Discov 4(5):554-63 PMID: 24631838
- 3. Buddham R et al.. 2022. Reconstruction and Exploratory Analysis of mTORC1 Signaling Pathway and Its Applications to Various Diseases Using Network-Based Approach.. J Microbiol Biotechnol 32(3):365-377 PMID: 35001007
- 4. Lupton CJ et al.. 2026. Structure of the lysosomal KICSTOR-GATOR1-SAMTOR nutrient-sensing supercomplex.. Cell 189(4):1185-1200.e28 PMID: 41512879
- 6. Ratto E et al.. 2022. Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly.. Nat Commun 13(1):4848 PMID: 35977928
- 7. Wang S et al.. 2024. Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis.. Circ Res 134(5):505-525 PMID: 38422177
- 8. Williams TD et al.. 2024. Distinct TORC1 signalling branches regulate Adc17 proteasome assembly chaperone expression.. J Cell Sci 137(14) PMID: 38949052
